Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

计划入组 63 人 · 首次发布于 2022 年 4 月 5 日

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

计划入组 45 人 · 首次发布于 2016 年 5 月 12 日

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

计划入组 119 人 · 首次发布于 2014 年 9 月 15 日

Bladder Cancer(Biomics Biotechnologies)

GSK-2302032A

BCG bladder cancer vaccine (Biofabri)

A&A SMALL CHANGES HANDYPEOPLE

United States

Gamida Cell

Israel

GAMIDA CELL INC.

United States

Perioperative Chemotherapy Shows Survival Benefit in Locoregional Small Cell Bladder Cancer

Pembrolizumab Plus Chemotherapy Improves Outcomes in Small Cell Bladder and Prostate Cancer

Daiichi Sankyo and Merck Expand Collaboration to Develop Novel DLL3-Targeting T-Cell Engager for Small Cell Lung Cancer